Literature DB >> 16276964

Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes.

Hyun-Jung Kim1, Sang Bum Lee, Song-Kyu Park, Hwan Mook Kim, Young In Park, Mi-Sook Dong.   

Abstract

Flavonoids are polyphenols composed of two aromatic rings (A, B) and a heterocyclic ring (C). In order to determine the effects of the number of hydroxyl groups in the B-ring of the flavonoids on human cytochrome P450 (CYP) 1 family enzymes, we evaluated the inhibition of CYP1A-dependent 7-ethoxyresorufin omicron-deethylation activity by chrysin, apigenin and luteolin, using bacterial membranes that co-express human CYP1A1, CYP1A2, or CYP1B1 with human NADPH-cytochrome P450 reductase. Chrysin, which possesses no hydroxyl groups in its B-ring, exhibited the most pronounced inhibitory effects on CYP1A2-dependent EROD activity, followed by apigenin and luteolin. On the contrary, CYP1A1-mediated EROD activity was most potently inhibited by luteolin, which is characterized by two hydroxyl groups in its B-ring, followed by apigenin and chrysin. However, all of the 5,7-dihydroxyflavones were determined to similarly inhibit CYP1B1 activity. Chrysin, apigenin, and luteolin exhibited a mixed-type mode of inhibition with regard to CYP1A2, CYP1B1, and CYP1A1, with apparent Ki values of 2.4, 0.5, and 2.0 microM, respectively. These findings suggested that the number of hydroxyl groups in the B-ring of 5,7-dihydroxyflavone might have some influence on the degree to which CYP1A enzymes were inhibited, but not on the degree to which CYP1B1 enzymes were inhibited.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16276964     DOI: 10.1007/bf02972971

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  12 in total

1.  Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study.

Authors:  Tsutomu Shimada; Katsuhiro Tanaka; Shigeo Takenaka; Maryam K Foroozesh; Norie Murayama; Hiroshi Yamazaki; F Peter Guengerich; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2009-07       Impact factor: 3.739

2.  Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.

Authors:  Tsutomu Shimada; Katsuhiro Tanaka; Shigeo Takenaka; Norie Murayama; Martha V Martin; Maryam K Foroozesh; Hiroshi Yamazaki; F Peter Guengerich; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2010-12-20       Impact factor: 3.739

3.  Preference for O-demethylation reactions in the oxidation of 2'-, 3'-, and 4'-methoxyflavones by human cytochrome P450 enzymes.

Authors:  Haruna Nagayoshi; Norie Murayama; Masaki Tsujino; Shigeo Takenaka; Jun Katahira; Vitchan Kim; Donghak Kim; Masayuki Komori; Hiroshi Yamazaki; F Peter Guengerich; Tsutomu Shimada
Journal:  Xenobiotica       Date:  2020-04-30       Impact factor: 1.908

Review 4.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

5.  Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2.

Authors:  Jayalakshmi Sridhar; Jamie Ellis; Patrick Dupart; Jiawang Liu; Cheryl L Stevens; Maryam Foroozesh
Journal:  Drug Metab Lett       Date:  2012

6.  Insight into the dynamic interaction between different flavonoids and bovine serum albumin using molecular dynamics simulations and free energy calculations.

Authors:  Xiaodi Niu; Xiaohan Gao; Hongsu Wang; Xin Wang; Song Wang
Journal:  J Mol Model       Date:  2012-11-01       Impact factor: 1.810

7.  The genotoxicity potential of luteolin is enhanced by CYP1A1 and CYP1A2 in human lymphoblastoid TK6 cells.

Authors:  Xilin Li; Xiaobo He; Si Chen; Yuan Le; Matthew S Bryant; Lei Guo; Kristine L Witt; Nan Mei
Journal:  Toxicol Lett       Date:  2021-03-13       Impact factor: 4.271

Review 8.  Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity.

Authors:  Tsutomu Shimada
Journal:  Toxicol Res       Date:  2017-04-15

9.  Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro.

Authors:  Junli Hong; Adryan Fristiohady; Chi H Nguyen; Daniela Milovanovic; Nicole Huttary; Sigurd Krieger; Junqiang Hong; Silvana Geleff; Peter Birner; Walter Jäger; Ali Özmen; Liselotte Krenn; Georg Krupitza
Journal:  Front Pharmacol       Date:  2018-03-14       Impact factor: 5.810

10.  The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity.

Authors:  Mirza Bojić; Martin Kondža; Hrvoje Rimac; Goran Benković; Željan Maleš
Journal:  Molecules       Date:  2019-09-01       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.